Small Biopharma Luina Bio is a Brisbane-based biopharmaceutical contract manufacturing organization with 51-200 employees and a focus on GMP manufacture of recombinant proteins, vaccines, and live bio-therapeutics for human and veterinary use, presenting a mid-sized CRO partner for early to mid-stage programs seeking scalable manufacturing and process development.

Diversified Capabilities The company offers end-to-end services from process development to GMP manufacturing for pre-clinical through Phase 3, enabling potential customers to consolidate development and production with a single partner to accelerate timelines and reduce coordination complexity.

Global Collaboration Luina Bio has a track record of working with Australian, European, American, and Asian clients, highlighting international exposure and the potential to attract global partnerships, technology transfer deals, and cross-border clinical manufacturing opportunities.

Strategic Partnerships Frequent partnerships and MoUs with universities and tech firms (Griffith University, Technovalia, XING Technologies) indicate openings for co-development, vaccine and diagnostic programs, and collaborative grant-funded initiatives that can be leveraged for joint go-to-market strategies.

Expansion Potential Recent news and platform initiatives such as the Luina Flexible Manufacturing Platform and multiple planned process development labs suggest capacity for expanding service offerings and scale, creating opportunities to upsell additional manufacturing capacity, tech transfer, and early-access programs for new clients.